Intermittently administered parathyroid hormone 1–34 reverses bone loss and structural impairment in orchiectomized adult rats

[1]  H. Oxlund,et al.  Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation. , 2004, Bone.

[2]  E. Glass,et al.  Teriparatide [PTH(1–34)] Strengthens the Proximal Femur of Ovariectomized Nonhuman Primates Despite Increasing Porosity , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  L. Qin,et al.  Parathyroid hormone: a double-edged sword for bone metabolism , 2004, Trends in Endocrinology & Metabolism.

[4]  R G Richards,et al.  Immunohistochemistry of matrix markers in Technovit 9100 New-embedded undecalcified bone sections. , 2003, European cells & materials.

[5]  J. Finkelstein,et al.  The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. , 2003, The New England journal of medicine.

[6]  Matthew R. Smith.  Management of treatment-related osteoporosis in men with prostate cancer. , 2003, Cancer treatment reviews.

[7]  A. Oberg,et al.  Fracture risk following bilateral orchiectomy. , 2003, The Journal of urology.

[8]  N. Dawson.  Therapeutic benefit of bisphosphonates in the management of prostate cancer-related bone disease , 2003, Expert opinion on pharmacotherapy.

[9]  J. Iwamoto,et al.  Effect of Vitamin K2 on Cortical and Cancellous Bones in Orchidectomized and/or Sciatic Neurectomized Rats , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  A. Díez-Pérez,et al.  The Effect of Teriparatide [Human Parathyroid Hormone (1–34)] Therapy on Bone Density in Men With Osteoporosis , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  S. Boonen,et al.  Evidence From the Aged Orchidectomized Male Rat Model That 17β‐Estradiol Is a More Effective Bone‐Sparing and Anabolic Agent Than 5α‐Dihydrotestosterone , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  W. Jee,et al.  Bipedal stance exercise and prostaglandin E2 (PGE2) and its synergistic effect in increasing bone mass and in lowering the PGE2 dose required to prevent ovariectomized-induced cancellous bone loss in aged rats. , 2002, Bone.

[13]  C. Turner,et al.  Skeletal efficacy with parathyroid hormone in rats was not entirely beneficial with long-term treatment. , 2002, The Journal of pharmacology and experimental therapeutics.

[14]  Lian-fang Huang,et al.  Effect of intermittent injection of recombinant human parathyroid hormone on bone histomorphometry of ovariectomized rats. , 2002, Acta pharmacologica Sinica.

[15]  J. Iwamoto,et al.  Comparative effects of intermittent administration of human parathyroid hormone (1-34) on cancellous and cortical bone loss in tail-suspended and sciatic neurectomized young rats , 2002, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[16]  J. Iwamoto,et al.  Effect of etidronate on bone in orchidectomized and sciatic neurectomized adult rats. , 2002, Bone.

[17]  R. Müller,et al.  Human Parathyroid Hormone 1–34 Reverses Bone Loss in Ovariectomized Mice , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  J. Reginster,et al.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.

[19]  H. Oxlund,et al.  The Influence of Combined Parathyroid Hormone and Growth Hormone Treatment on Cortical Bone in Aged Ovariectomized Rats , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  R. L. Cain,et al.  Six‐Month Daily Administration of Parathyroid Hormone and Parathyroid Hormone—Related Protein Peptides to Adult Ovariectomized Rats Markedly Enhances Bone Mass and Biomechanical Properties: A Comparison of Human Parathyroid Hormone 1–34, Parathyroid Hormone‐Related Protein 1–36, and SDZ‐Parathyroid , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  P. Rüegsegger,et al.  Direct Three‐Dimensional Morphometric Analysis of Human Cancellous Bone: Microstructural Data from Spine, Femur, Iliac Crest, and Calcaneus , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  Wei Wei,et al.  Parathyroid Hormone and Mechanical Usage Have a Synergistic Effect in Rat Tibial Diaphyseal Cortical Bone , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  R. Lindsay,et al.  Is Parathyroid Hormone a Therapeutic Option for Osteoporosis? A Review of the Clinical Evidence , 1998, Calcified Tissue International.

[24]  T. Wronski,et al.  Time course of femoral neck osteopenia in ovariectomized rats. , 1996, Bone.

[25]  F. Cohen,et al.  Bone‐selective analogs of human PTH(1–34) increase bone formation in an ovariectomized rat model , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  R. Lindsay,et al.  Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  E. Orwoll,et al.  Early induction of alterations in cancellous and cortical bone histology after orchiectomy in mature rats , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  T. Wronski,et al.  Response of femoral neck to estrogen depletion and parathyroid hormone in aged rats. , 1995, Bone.

[29]  L. Mosekilde,et al.  The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength--assessed in a sexually mature, ovariectomized rat model. , 1995, Bone.

[30]  W. Jee,et al.  Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  R. Isaacs,et al.  Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  J. Hock,et al.  Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  J. Hock,et al.  Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats. , 1988, Endocrinology.

[34]  M. Drezner,et al.  Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  Matthew R. Smith.  Bisphosphonates to Prevent Osteoporosis in Men Receiving Androgen Deprivation Therapy for Prostate Cancer , 2003, Drugs & aging.